Third Harmonic Bio
THRD
THRD was delisted on the 30th of July, 2025.
96 hedge funds and large institutions have $463M invested in Third Harmonic Bio in 2024 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 37 increasing their positions, 19 reducing their positions, and 13 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
95% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 19
92% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 13
14% more funds holding
Funds holding: 84 → 96 (+12)
7.36% less ownership
Funds ownership: 107.12% → 99.76% (-7.4%)
22% less capital invested
Capital invested by funds: $597M → $463M (-$134M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$27.8M |
| 2 |
DM
Deerfield Management
New York
|
+$12.7M |
| 3 |
Millennium Management
New York
|
+$6.96M |
| 4 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$6.24M |
| 5 |
GA
General Atlantic
New York
|
+$5.15M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$24.8M |
| 2 |
CC
Commodore Capital
New York
|
-$14M |
| 3 |
AVLSA
Atlas Venture Life Science Advisors
Cambridge,
Massachusetts
|
-$6.3M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$6.25M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$4.33M |
THRD Hedge Fund Activity: Q4 2024 in Review
96 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Third Harmonic Bio (THRD) for Q4 2024, worth a combined $463M — down 22% from $597M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new THRD positions and 13 closed out — a net gain of 12 holders — while 37 added to existing stakes and 19 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $27.8M. The largest seller was BVF Inc, cutting an estimated $24.8M.
- 96 institutional investors held Third Harmonic Bio (THRD) as of Q4 2024, up from 84 in Q3 2024.
- Funds reported $463M of Third Harmonic Bio stock for Q4 2024, down 22% quarter-over-quarter.
- 25 funds opened new Third Harmonic Bio positions in Q4 2024 and 13 closed out, a net change of +12 holders.
- The largest Third Harmonic Bio buyer in Q4 2024 was Fidelity Investments, an estimated $27.8M added.
- The largest Third Harmonic Bio seller in Q4 2024 was BVF Inc, an estimated $24.8M sold.
Based on aggregated 13F filings for Q4 2024.